Evonile Pharma Ltd share price logo

Evonile Pharma Ltd

NSE: EVONILE

BSE: 500672

Small Cap

Pharma Sector

₹1716.50

+2.20

(+0.13%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Key Events for Novartis India

Last Dividend Declared

₹25.00 per share, declared on 09/05/2025

View Dividend History

Novartis India Stock Performance

as on November 5, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹1,651.00
    ₹1,730.00
    downward going graph

    3.82%

    Downside

    0.79%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹950.00
    ₹2,588.80
    downward going graph

    44.65%

    Downside

    50.82%

    Upside

    downward going graph

Novartis India share price movements today

Previous Close
₹1,714.30
Open
₹1,701.00
Volume
61.38K
Upper Circuit
₹2,057.10
Lower Circuit
₹1,371.50
Day's Low - High
₹1,651.00 - ₹1,730.00
52 Week Low - High
₹950.00 - ₹2,588.80

Novartis India Historical Returns

1 Month Return
-12.88 %
3 Month Return
+ 4.86 %
1 Year Return
+ 103.95 %
3 Year Return
+ 158.12 %
5 Year Return
+ 112.92 %

Novartis India Fundamentals

as on November 5, 2026 at 4:01 pm IST

Market Cap

₹4,232.74 Cr

Return on Equity (ROE)

11.63

PE Ratio (TTM)

-1064.78

Return on capital employed (ROCE)

15.94

Industry PE ratio

52.28

Beta (LTM)

-0.27

P/B Ratio

2.93

Dividend Yield

0

PEG Ratio

23.77

Quarterly Earnings Growth YOY

-420.15

EPS (TTM)

0

Book Value

0

Novartis India Stock Valuation

as on November 5, 2026 at 4:01 pm IST

Novartis India in the last 5 years

  • Overview

  • Trends

Lowest (-1274.04x)

October 6, 2026

Today (-1064.78x)

November 4, 2026

Industry (52.28x)

November 4, 2026

Highest (113.24x)

July 14, 2021

LowHigh

Today’s Price to Earnings Ratio: -1064.78x

Novartis India Technical Analysis

Track how Novartis India technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish4
Bullish10
Neutral1

Oscillators

Name

Value

Action

MACD level (12,26)
2.11
Bullish
CCI (20)
-311.12
Bullish
RSI (14)
59.18
Neutral
Momentum (10)
5.3
Bearish
ADI (14)
28.77
Bullish
Ultimate Oscillator (7,14,28)
74.35
Bullish

Moving Averages

Name

Value

Action

SMA (20)
1710.72
Bullish
EMA (20)
1711.86
Bullish
VWMA (20)
1712.28
Bullish
SMA (50)
1707.13
Bullish
EMA (50)
1710.88
Bullish
SMA (200)
1720.81
Bearish
EMA (200)
1716
Bearish
KAMA (200)
1708.64
Bullish
DEMA (200)
1715.85
Bearish

Evonile Pharma Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Novartis India with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Evonile Pharma Ltd image
Evonile Pharma Ltd
NA4,232.7422.58%0.0093376
Zota Health Care Ltd image
Zota Health Care Ltd
BUY4,217.9045.98%0.64-75538
Pentokey Organy (India) Ltd image
Pentokey Organy (India) Ltd
NA18.1810.76%0.0032
Haleos Labs Limited image
Haleos Labs Limited
NA422.8412.32%0.6917333
Zenlabs Ethica Ltd image
Zenlabs Ethica Ltd
NA17.49-4.9%0.00-246
See all

Evonile Pharma Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Sales
84.54
81.17
92.29
87.1
93
83.88
87.55
90.33
85.9
90.55
103.81
56.05
Other Income
21.96
10.42
10.41
10.32
10.6
10.63
10.61
9.4
8.75
10.01
8.74
7.74
Total Income
106.5
91.59
102.7
97.42
103.6
94.51
98.16
99.73
94.65
100.56
112.55
63.79
Expenses
64.77
69.96
68.32
69.14
67.42
59.97
60.31
66.45
63.54
69.93
68.9
156.13
Operating Profit
19.77
11.21
23.97
17.96
25.58
23.91
27.24
23.88
22.36
20.62
34.91
-100.08
Operating Profit Margin %
23.39%
13.81%
25.97%
20.62%
27.51%
28.51%
31.11%
26.44%
26.03%
22.77%
33.63%
-178.55%
Profit Before Interest, Tax and Depreciation
41.73
21.63
34.38
28.28
36.18
34.54
37.85
33.28
31.11
30.63
43.65
-92.34
Interest
0.16
0.16
0.15
0.14
0.36
0.12
0.1
0.11
0.98
0.07
0.06
4.83
Depreciation
0.26
0.14
0.55
0.58
0.53
0.53
0.53
0.52
0.48
0.42
0.42
3.89
Profit Before Tax
41.31
21.33
33.68
27.56
35.29
33.89
37.22
32.65
29.65
30.14
43.17
-101.06
Tax Paid
14.74
6.65
7.94
7.15
9.84
4.59
9.6
8.43
13.56
4.89
10.96
-23.52
Profit After Tax
26.57
14.68
25.74
20.41
25.45
29.3
27.62
24.22
16.09
25.25
32.21
-77.54
Total Net profit including share of profit / Loss from associate company
26.57
14.68
25.74
20.41
25.45
29.3
27.62
24.22
16.09
25.25
32.21
-77.54
EPS
10.76
5.95
10.42
8.27
10.31
11.87
11.19
9.81
6.52
10.23
13.05
-31.41
Actual EPS
10.76
5.95
10.42
8.27
10.31
11.87
11.19
9.81
6.52
10.23
13.05
-31.41
Adjusted EPS
10.76
5.95
10.42
8.27
10.31
11.87
11.19
9.81
6.52
10.23
13.05
-31.41
Diluted EPS
10.76
5.95
10.42
8.27
10.31
11.87
11.19
9.81
6.52
10.23
13.05
-31.41

Evonile Pharma Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
563.88
490.68
438.25
381.35
399.87
378.74
335.07
356.27
354.33
Other Income
171.83
78.26
36.14
33.09
33.19
58.11
61.68
41.96
38.77
Total Income
735.71
568.94
474.39
414.44
433.06
436.85
396.75
398.23
393.1
Expenses
570.13
478.4
426.22
354.56
422.4
313.66
269.81
264.85
260.23
Operating Profit
-6.25
12.28
12.03
26.79
-22.53
65.08
65.26
91.42
94.1
Operating Profit Margin %
-1.11%
2.5%
2.75%
7.03%
-5.63%
17.18%
19.48%
25.66%
26.56%
Profit Before Interest, Tax and Depreciation
165.58
90.54
48.17
59.88
10.66
123.19
126.94
133.38
132.87
Interest
5.53
1.59
6.39
7.68
4.83
1.75
1.49
0.77
1.26
Depreciation
2.53
3.18
13.14
12.16
9.65
6.06
2.61
2.19
1.95
Profit Before Tax
157.52
85.77
28.64
40.04
-3.82
115.38
122.84
130.42
129.66
Tax Paid
79.16
34
18.56
19.14
-0.1
12.02
37.65
29.52
36.48
Profit After Tax
78.36
51.77
10.08
20.9
-3.72
103.36
85.19
100.9
93.18
Total Net profit including share of profit / Loss from associate company
78.36
51.77
10.08
20.9
-3.72
103.36
85.19
100.9
93.18
EPS
28.43
20.97
4.08
8.46
-1.51
41.86
34.5
40.87
37.74
Actual EPS
28.43
20.97
4.08
8.46
-1.51
41.86
34.5
40.87
37.74
Adjusted EPS
28.43
20.97
4.08
8.46
-1.51
41.86
34.5
40.87
37.74
Diluted EPS
28.43
20.97
4.08
8.46
-1.51
41.86
34.5
40.87
37.74

Evonile Pharma Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
56.59
-40.83
160.99
-194.28
-23.14
-69.21
38.67
44.8
113.4
74.57
46.73
Cash Flow from Investing Activities
-630.47
423.64
68.7
274.23
55.91
95.16
87.04
-153.25
33.13
-3.31
17.63
Cash Flow from Financing Activities
-38.57
-331.8
-267.65
-29.82
-41.41
-36.8
-35.63
-30.48
-120.99
-64.15
-63.93
Net Cash Flow
-612.45
51.01
-37.96
50.13
-8.64
-10.85
90.08
-138.93
25.54
7.11
0.43

Novartis India Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Jul 2026
Sep 2026
Promoters
70.68%
70.68%
70.68%
70.68%
70.68%
70.68%
70.68%
70.68%
70.68%
70.68%
70.68%
70.68%
70.68%
DII
0.53%
0.53%
0.53%
0.53%
0.53%
0.53%
0.53%
0.53%
0.64%
0.53%
1.36%
1.39%
1.5%
FII
0.19%
0.19%
0.19%
0.19%
0.19%
0.19%
0.19%
0.19%
0.19%
0.17%
0.16%
0.15%
1.22%
Public
28.59%
28.6%
28.6%
28.6%
28.6%
28.6%
28.6%
28.6%
28.5%
28.61%
27.8%
27.78%
26.6%
Total Outstanding Shares
2,46,90,797
2,46,90,797
2,46,90,797
2,46,90,797
2,46,90,797
2,46,90,797
2,46,90,797
2,46,90,797
2,46,90,797
2,46,90,797
2,46,90,797
2,46,90,797
2,46,90,797
Total Shareholders
43,128
41,239
39,265
39,596
38,926
39,133
39,040
39,353
39,468
38,116
36,502
36,706
38,127

Mutual Funds Buying / Exiting Novartis India

Holdings as of 15 Oct 2026 · based on the latest SEBI-mandated portfolio disclosures

Mutual Funds Buying Novartis India

Sorted by largest increase in holding, month-over-month.

No buying activity data available right now

No buying activity data available right now

Mutual Funds Exiting Novartis India

Sorted by largest decrease in holding, month-over-month.

Fund Name

Value of Holding

Decrease (MoM)

Holding %

HDFC MNC Fund Direct Growth

HDFC MNC Fund Direct Growth

₹2.10 Cr

₹1.29 Cr (-38.02%)

0.44%

Novartis India Corporate Actions

View detailed summary of the earnings and dividend history of Novartis India.

  • Novartis India Ltd Earnings Results

    Novartis India Ltd’s net profit fell -420.15% since last year same period to ₹-77.54Cr in the Q2 2026-2027. On a quarterly growth basis, Novartis India Ltd has generated -340.73% fall in its net profits since last 3-months.

    Read More

  • Novartis India Ltd Dividends May,2025

    In the quarter ending March 2025, Novartis India Ltd has declared dividend of ₹25.00 per share on 09 May 2025 - translating a dividend yield of 2.90%.

    Read More about Dividends

Indices Featuring Novartis India Stock

Check stock indices that include Novartis India.

BSE Healthcare

₹51,423.13

+332.24 (▲0.65%)

Insights on Evonile Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 0.72% to 0.77% in Sep 2026 quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.15% to 1.22% in Sep 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Laurus Labs Ltd has given 137.2% return, outperforming this stock by 33.2%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 70.68% of holdings in Sep 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Laurus Labs Ltd has given 524.0% return, outperforming this stock by 365.9%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 27.78% to 26.60% in Sep 2026 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, EVONILE stock has moved down by -5.4%

About Evonile Pharma Ltd

Novartis India Limited (NIL) is a subsidiary of the world's second-largest pharmaceutical company, Swiss giant Novartis. Incorporated in 1947, the company has four core segments- Pharmaceuticals, Generics, Over the Counter, and Animal Health. Its history traces back to the middle of the 18th century when Geigy was founded, followed by Ciba in 1860 and then Sandoz in 1886. It was only in 1996 when the three separate entities merged to become Novartis. In 2000, the company acquired products from SmithKline Beecham and started a Joint Effort to Eradicate Tuberculosis (JEET) in India. The Glivec drug was launched in India in 2002 for which they were awarded TERI's Corporate Social Responsibility award. Over the years the company has alligned with various global organisations inlcuding the WHO to help stem the spread of malaria, as well as launching numerous initiatives including the Arogya Parivar in 2008 to target healthcare needs of villagers. Moreover, between 2000 and 2006, it spent over USD 755 million on research for neglected diseases and patient-access programs.

Revenue: ₹56.05Cr as on September 2026 (Q2 FY27)
Net Profit: ₹-77.54Cr as on September 2026 (Q2 FY27)
Listing date: 08 Nov, 1994
Chairperson Name: C Snook
OrganisationEvonile Pharma Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOC Snook
E-voting on sharesClick here to vote

FAQs

What is Novartis India share price today?

Novartis India share price today stands at ₹1716.5 as on at the close of the market. Novartis India share today touched a day high of ₹1730 and a low of ₹1651.

What is the 52 week high and 52 week low range for Novartis India share?

Novartis India touched a 52 week high of ₹2588.8 and a 52 week low of ₹950. Novartis India share price today i.e. is closed at ₹1716.5, which is -33.70% down from its 52 week high and 80.68% up from its 52 week low.

What is Novartis India's market capitalisation today?

Novartis India market capitalisation is ₹4,232.74 Cr as on .

How to buy Novartis India shares?

To buy Novartis India shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for EVONILE or Evonile Pharma Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Novartis India shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Novartis India trading volume today?

Novartis India trading volume is 61.38K as on . This means that 61.38K shares of Novartis India were bought and sold on the stock market during today's trading session.